1. Eli Lilly and Company
2. Pfizer Inc.
3. GlaxoSmithKline plc
4. Novartis International AG
5. Merck & Co. Inc.
6. Abbott Laboratories
7. Johnson & Johnson
8. Boehringer Ingelheim
| Published | Pages | Publisher | Report code |
|---|---|---|---|
| Mar 2022 | 180 | Renub Research | ASDR-598638 |
1. Eli Lilly and Company
2. Pfizer Inc.
3. GlaxoSmithKline plc
4. Novartis International AG
5. Merck & Co. Inc.
6. Abbott Laboratories
7. Johnson & Johnson
8. Boehringer Ingelheim
Published: June, 2025 | Report code: ASDR-676508
US $
Euro €
GBP £